FIELD: pharmacology.
SUBSTANCE: invention relates to an inhibitor of a migration inhibition factor for macrophages containing a benzopyran derivative represented by the general formula [1] or a salt thereof, wherein R1 is a C1-6 alkyl group; one of R2 and R3 is a hydrogen atom and the other of R2 and R3 is a hydrogen atom, an amino group, an acylamino group, a carbamoyl group or an aryl group, as well as a drug against neuropathic pain, excluding the symptoms of allodynia in neuropathic pain, based on the compounds of formula I.
EFFECT: increased means effeciency.
9 cl, 4 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC AGENT FOR DISEASES BASED ON THE INHIBITORY EFFECT ON THE INHIBITION FACTOR OF MACROPHAGE MIGRATION | 2014 |
|
RU2750540C2 |
ACID ADDITION SALT OF TRK INHIBITING COMPOUND | 2015 |
|
RU2708236C2 |
METHOD OF TREATMENT OF PATIENTS WITH PROSTATE BENIGNITY HYPERPLASIA, PHARMACEUTICAL PREPARATION CONTAINING INHIBITOR OF 5-ALPHA-REDUCTASE | 1992 |
|
RU2125879C1 |
NEW PREVENTIVE AND/OR THERAPEUTIC AGENT FOR NEUROPATHIC PAIN | 2008 |
|
RU2462459C2 |
TRK-INHIBITING COMPOUND | 2014 |
|
RU2667907C9 |
BICYCLIC CARBOXYLIC ACIDS INHIBITING BIOLOGICAL ACTIVITY OF LEUKOTRIENE B AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2137765C1 |
SULPHONAMIDE COMPOUND AND SALT THEREOF | 2007 |
|
RU2425029C2 |
SULFONAMIDE COMPOUNDS AND SALTS THEREOF | 2009 |
|
RU2481329C2 |
NEW TREATMENT OF MULTIPLE SCLEROSIS (MS) | 2011 |
|
RU2595861C2 |
DIAMINOHETEROCYCLIC CARBOXAMIDE COMPOUND | 2010 |
|
RU2526253C2 |
Authors
Dates
2018-01-17—Published
2014-07-17—Filed